Rockeby biomed Limited is an ASX-listed (ASX: RBY) biotechnology company engaged primarily in the research, development and marketing of products for the diagnosis and treatment of fungal infections in humans. The company's main market is that of in-vitro diagnostic testing which covers serology tests in hospitals as well as point-of-care products for use by consumers or health professionals operating outside hospitals.

	Fax	(08) 9368 2922
	Principal Sector	Health & Pharm
	Principal Industry	Biotechnology
	Listed	2003/12/23
	Homepage	www.rockeby.com

Stock Exchange Stock Code   ASX:RBY RBY ZOBEX RBY

Rockeby Biomed Limited ASX: RBY - Avian Flu Test Selected For Canadian Trial - Dr Sze Wee Tan, Chief Executive (OCT 25, 2007)

Rockeby Biomed Limited ASX: RBY - September 2007 Quarterly - Dr Sze Wee Tan, Chief Executive (OCT 24, 2007)

Rockeby Biomed Limited ASX: RBY - Will Participate In Intersuisse London Biotech Forum - Dr Sze Wee Tan, Chief Executive (OCT 3, 2007)

Rockeby Biomed Limited ASX: RBY - 2007 Full Year Results - Dr Sze Wee Tan, Chief Executive (SEP 3, 2007)

Rockeby Biomed Limited ASX: RBY - Japan Patent Granted For CanDia5 - Dr Sze Wee Tan, Chief Executive (AUG 16, 2007)

Rockeby Biomed Limited ASX: RBY - Awarded EDB Grant To Develop Hand Foot Mouth Disease Test - Dr Sze Wee Tan, Chief Executive (AUG 13, 2007)

Rockeby Biomed Limited ASX: RBY - Singaporean Clinics Approve Oral HIV Test, OraQuick - Dr Sze Wee Tan, Chief Executive (AUG 2, 2007)

Rockeby Biomed Limited ASX: RBY - June 2007 Quarterly - Dr Sze Wee Tan, Chief Executive (AUG 2, 2007)

Rockeby Biomed Limited ASX: RBY - Pepp to be Launched in Europe and Singapore - Dr Sze Wee Tan, Chief Executive (JUNE 14, 2007)

Rockeby Biomed Limited ASX: RBY - Plans to Market Pepp Hangover Remedy in China with Sandoz - Dr Sze Wee Tan, Chief Executive (JUNE 14, 2007)

Rockeby Biomed Limited ASX: RBY - Bird Flu Research Presentation at Pasteur Institute - Dr Sze Wee Tan, Chief Executive (MAY 18, 2007)

Rockeby Biomed Limited ASX: RBY - March 2007 Quarterly and Milestone Report - Dr Sze Wee Tan, Chief Executive (APR 30, 2007)

Rockeby Biomed Limited ASX: RBY - Secures UK Distribution Partner for Candia5 - Dr Sze Wee Tan, Chief Executive (APR 26, 2007)

Rockeby Biomed Limited ASX: RBY - Murdoch University Confirms Effectiveness of Bird Flu Test - Dr Sze Wee Tan, Chief Executive (APR 17, 2007)

Rockeby Biomed Limited ASX: RBY - Receives European OTC Approval for Candia5 - Dr Sze Wee Tan, Chief Executive (APR 2, 2007)

Rockeby Biomed Limited ASX: RBY - Progress of ANHEAL (Beijing) Acquisition - Dr Sze Wee Tan, Chief Executive (MAR 22, 2007)

Rockeby Biomed Limited ASX: RBY - To Supply Bird Flu Tests to Turkey - Dr Sze Wee Tan, Chief Executive (MAR 12, 2007)

Rockeby Biomed Limited ASX: RBY - 2007 Half Year Results - Dr Sze Wee Tan , Chief Executive (FEB 26, 2007)

Rockeby Biomed Limited ASX: RBY - December Quarterly and Milestone Report - Dr Sze-Wee Tan, Chief Executive (JAN 25, 2007)

Rockeby Biomed Limited ASX: RBY - Rockeby Biomed Licenses Test For Pre-Eclampsia - Dr Sze-Wee Tan, Chief Executive (JAN 18, 2007)